欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0235/002
药品名称PRILACTONE NEXT 50 MG chewable tablets
活性成分
    • spironolactone 20.0 mg
剂型Tablet
上市许可持有人Ceva Santé Animale 10 avenue de la Ballastière 33500 Libourne France
参考成员国 - 产品名称France (FR)
PRILACTIONE NEXT 50 MG (13203)
互认成员国 - 产品名称
    • Germany (DE)
      Tempora 50 mg chewable tablets
    • Belgium (BE)
      Prilactone Next 50 mg
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
      Tempora 50 mg Chewable Tablets for Dogs
    • Ireland (IE)
      Tempora 50 mg chewable tablets for dogs
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Finland (FI)
    • Poland (PL)
许可日期2012/05/23
最近更新日期2022/12/09
药物ATC编码
    • QC03DA01 spironolactone
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase